Prospective, Multicenter Clinical Trial of Everolimus as Primary Therapy in Waldenstrom Macroglobulinemia (WMCTG 09-214)

Steven P. Treon; Kirsten Meid; Christina Tripsas; Leonard T. Heffner; Herbert Eradat; Ashraf Z. Badros; Lian Xu; Zachary R. Hunter; Guang Yang; Christopher J. Patterson; Joshua Gustine; Jorge J. Castillo; Jeffrey Matous; Irene M. Ghobrial

doi:10.1158/1078-0432.CCR-16-1918

Prospective, Multicenter Clinical Trial of Everolimus as Primary Therapy in Waldenstrom Macroglobulinemia (WMCTG 09-214)

Steven P. Treon
, Kirsten Meid
, Christina Tripsas
, Leonard T. Heffner
, Herbert Eradat
, Ashraf Z. Badros
, Lian Xu
, Zachary R. Hunter
, Guang Yang
, Christopher J. Patterson
, Joshua Gustine
, Jorge J. Castillo
, Jeffrey Matous
, Irene M. Ghobrial

Harvard University
Emory University
University of California, Los Angeles
University of Maryland, Baltimore
Rocky Mountain Cancer Center, Denver, Colorado.

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Clinical Cancer Research
Volume	23
Issue number	10
DOIs	https://doi.org/10.1158/1078-0432.CCR-16-1918
State	Published - May 15 2017
Externally published	Yes

Disciplines

Medicine and Health Sciences
Gastroenterology
Surgery
Internal Medicine

Access to Document

10.1158/1078-0432.CCR-16-1918License: Unspecified

Cite this

Treon, S. P., Meid, K., Tripsas, C., Heffner, L. T., Eradat, H., Badros, A. Z., Xu, L., Hunter, Z. R., Yang, G., Patterson, C. J., Gustine, J., Castillo, J. J., Matous, J., & Ghobrial, I. M. (2017). Prospective, Multicenter Clinical Trial of Everolimus as Primary Therapy in Waldenstrom Macroglobulinemia (WMCTG 09-214). Clinical Cancer Research, 23(10). https://doi.org/10.1158/1078-0432.CCR-16-1918

Treon, SP, Meid, K, Tripsas, C, Heffner, LT, Eradat, H, Badros, AZ, Xu, L, Hunter, ZR, Yang, G, Patterson, CJ, Gustine, J, Castillo, JJ, Matous, J & Ghobrial, IM 2017, 'Prospective, Multicenter Clinical Trial of Everolimus as Primary Therapy in Waldenstrom Macroglobulinemia (WMCTG 09-214)', Clinical Cancer Research, vol. 23, no. 10. https://doi.org/10.1158/1078-0432.CCR-16-1918

@article{82e10d1f21a94b7883d45e7e8f318e02,

title = "Prospective, Multicenter Clinical Trial of Everolimus as Primary Therapy in Waldenstrom Macroglobulinemia (WMCTG 09-214)",

author = "Treon, \{Steven P.\} and Kirsten Meid and Christina Tripsas and Heffner, \{Leonard T.\} and Herbert Eradat and Badros, \{Ashraf Z.\} and Lian Xu and Hunter, \{Zachary R.\} and Guang Yang and Patterson, \{Christopher J.\} and Joshua Gustine and Castillo, \{Jorge J.\} and Jeffrey Matous and Ghobrial, \{Irene M.\}",

year = "2017",

month = may,

day = "15",

doi = "10.1158/1078-0432.CCR-16-1918",

language = "American English",

volume = "23",

journal = "Clinical Cancer Research",

issn = "1557-3265",

publisher = "American Association for Cancer Research",

number = "10",

}

TY - JOUR

T1 - Prospective, Multicenter Clinical Trial of Everolimus as Primary Therapy in Waldenstrom Macroglobulinemia (WMCTG 09-214)

AU - Treon, Steven P.

AU - Meid, Kirsten

AU - Tripsas, Christina

AU - Heffner, Leonard T.

AU - Eradat, Herbert

AU - Badros, Ashraf Z.

AU - Xu, Lian

AU - Hunter, Zachary R.

AU - Yang, Guang

AU - Patterson, Christopher J.

AU - Gustine, Joshua

AU - Castillo, Jorge J.

AU - Matous, Jeffrey

AU - Ghobrial, Irene M.

PY - 2017/5/15

Y1 - 2017/5/15

UR - https://clincancerres.aacrjournals.org/content/clincanres/23/10/2400.full.pdf

U2 - 10.1158/1078-0432.CCR-16-1918

DO - 10.1158/1078-0432.CCR-16-1918

M3 - Article

SN - 1557-3265

VL - 23

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 10

ER -

Prospective, Multicenter Clinical Trial of Everolimus as Primary Therapy in Waldenstrom Macroglobulinemia (WMCTG 09-214)

Disciplines

Access to Document

Other files and links

Cite this